What’s Behind $211,680 Sale at Vicor as AI Demand Surges
A tiny insider sale can spark big questions. This article explains what’s behind $211,680 sale, how Vicor’s AI-led de...
Discover effective wealth growth strategies for beginners that pave the way to financial success. Start learning and investing wisely now.
23,833 articlesA tiny insider sale can spark big questions. This article explains what’s behind $211,680 sale, how Vicor’s AI-led de...
As Angiodynamics (ANGO) gears up for the 2026 earnings season, investors should focus on orders, backlog, margins, an...
As the U.S. ramps up nuclear capacity, one stock could benefit from policy shifts, domestic fuel security, and growin...
Biodesix faces a pivotal year in 2025. This guide breaks down the factors shaping biodesix (bdsx) 2025 earnings, the ...
The Nasdaq-100 has delivered eye-catching runs, but 2026 brought a pause. This guide breaks down what to watch, how t...
A seasoned fund boosted its stake in ZoomInfo, revealing a confident bet on GTM's growth story. This article explains...
Marvell Technology stock today is moving on a mix of data-center demand, strategic bets, and fresh analyst optimism. ...
Microsoft’sAI push fuels cloud and enterprise gains even as capital outlays rise and OpenAI losses widen. Analysts ma...
What could Palantir's stock do by the end of 2027? This article builds three forward-looking scenarios, weighs risks,...
After a prolonged rally, the AI-heavy trade just worst stretch put gains on pause. This article outlines three clear ...
Two very different consumer stocks sit at the crossroads of retail: American Eagle Outfitters and Chewy. This analysi...
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...